Loading...
Publication: Colchicine for COVID-19: Rapid review of the evidence for clinical benefit and harm
Blockman, M ; Cohen, K ; De Waal, R ; Gray, A ; Kredo, T ; Nel, J ; Parrish, A ; Rees, H ; Reubenson, G
Blockman, M
Cohen, K
De Waal, R
Gray, A
Kredo, T
Nel, J
Parrish, A
Rees, H
Reubenson, G
Citations
Altmetric:
Abstract
Description
Colchicine, an oral anti-inflammatory drug used to treat gout, has been proposed as a potential treatment for COVID-19.Its mechanisms of action include inhibition of neutrophil and monocyte recruitment, and inhibition of proinflammatory cytokines, both of which are thought to be important mediators of COVID-19 disease severity.
Date
2021-11-19
Journal Title
Journal ISSN
Volume Title
Publisher
South African National Department of Health
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Colchicine,Anti-inflammatory drug,Rapid review,Treatment for COVID-19